The staining intensity of Ki67+, p-ERK+, and p-CDK2+ in the island-resident tumor cells was reduced after GDC-0623 treatment (Figure 9, G–I, and K–M), evidence that the drug had on-target effects and reduced tumor cell proliferation. The gene discussed is CDK2; the disease is neoplasm.